Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 26, 2025
Stryker announces intention to nominate Manny Maceda to board of directors
GlobeNewswire
·
March 26, 2025
Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025. …
FDA Recognizes Newly Revised AAMI Sterilization, Ethylene Oxide Guidance
GlobeNewswire
·
March 26, 2025
Arlington, VA, March 26, 2025 (GLOBE NEWSWIRE) -- AAMI is pleased to announce that the FDA has amended its database of Recognized Consensus Standards, adding multiple AAMI documents in the agency’s latest round of updates announced in March 2025. This …
Dietary Supplements Industry Poised for $258.75 Billion Growth by 2029
GlobeNewswire
·
March 26, 2025
Delray Beach, FL, March 26, 2025 (GLOBE NEWSWIRE) -- The global dietary supplements market is experiencing substantial growth, with an estimated valuation of USD 179.53 billion in 2024. Projections indicate a robust compound annual growth rate (CAGR) of 7. …
Best SARMs For Bulking, Cutting, Muscle Growth, Fat Loss Where to buy SARMs, Alternative Stack For Sale - CrazyBulk
GlobeNewswire
·
March 26, 2025
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- SARMs for Bulking If you want to build muscle faster than usual, SARMs for bulking can help. Using a SARMs stack (a combination of supplements) gives better results than using just one supplement. This guide …
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
GlobeNewswire
·
March 26, 2025
SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, due to the potential for immune mechanism synergies and …
New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate regulatory grade research
GlobeNewswire
·
March 26, 2025
BELLEVUE, Wash., March 26, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. The company also announced two …
Dr. Lyudmila Sarder Receives Prestigious U.S. Congressional Award for Women’s History Month
GlobeNewswire
·
March 26, 2025
WASHINGTON, March 26, 2025 (GLOBE NEWSWIRE) -- Dr. Lyudmila Sarder, MD, a highly esteemed internal medicine resident physician, has been honored with United States Congressional Recognition for her outstanding contributions to healthcare across Central …
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
GlobeNewswire
·
March 26, 2025
Los Angeles, CA, March 26, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, is pleased to announce …
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
March 26, 2025
MIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced management will present at the 24th Annual …
Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
GlobeNewswire
·
March 26, 2025
CORAL GABLES, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, or “the Company”), a clinical-stage biotechnology company committed to advancing innovative breakthrough therapies, today announced plans to host a …
Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment
GlobeNewswire
·
March 26, 2025
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel …
Bluejay Therapeutics Announces First Patient Dosed in AZURE-1 Global Pivotal Clinical Trial Evaluating Brelovitug (BJT-778) as a Monotherapy Treatment for Chronic Hepatitis D
GlobeNewswire
·
March 26, 2025
REDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced that the first …
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
GlobeNewswire
·
March 26, 2025
Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned entry into multi-billion dollar U.S. market in 2025 NEW …
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3
GlobeNewswire
·
March 26, 2025
Houston, TX, March 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) is pleased to invite investors to a webinar on April 3, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will …
Prime Biome Reviews Controversy Disclosure Report: Surprising Facts and Figures Revealed
GlobeNewswire
·
March 26, 2025
ST. PETERSBURG, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- In today's fast-paced world, guts and skin health has become a crucial aspect of total wellbeing. Prime Biome Gummies have attracted a lot of attention in the rapidly changing fields of intestinal …
Infinnium Launches BECProfiler™: A Cutting-Edge Solution to Automate Business Email Compromise Investigations
EIN Presswire
·
March 26, 2025
Business Email Compromise Investigations are time consuming, manual, and costly. BECProfiler™ reduces the time to minutes and lowers cost. CHANTILLY, VA, UNITED STATES, March 26, 2025 /EINPresswire.com/ -- Infinnium, a leader in AI-driven data privacy …
BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference
GlobeNewswire
·
March 26, 2025
PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to …
Next Featured Solution Provider for Mostly Medicaid StarSearch Series: Rosarium Health (Show date- April 18th, 2025)
EIN Presswire
·
March 26, 2025
The next installment of Medicaid StarSearch features Rosarium Health founder Cameron Carter and his vision to unlock the home modification benefit for members. BIRMINGHAM, AL, UNITED STATES, March 25, 2025 /EINPresswire.com/ -- MostlyMedicaid virtual …
C&F Plumbing Expands with New Location in Mountain Lakes, NJ
EIN Presswire
·
March 26, 2025
C…
Aligos Therapeutics Presents Positive Data at APASL 2025
GlobeNewswire
·
March 26, 2025
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral …